Wyeth Ltd(Merged)

Wyeth Ltd(Merged) | Sector: Pharmaceuticals | ISIN: INE378A01012

₹ 1,333.85 (-2.24%) icon9 Dec, 2014, 12:00:00 AM

undefined KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 12/9/2014 12:00:00 AM

    ₹ 1333.85 -30.50 -2.24
  • Open
  • ₹ 1,372
  • Prev. Close
  • ₹ 1,364.35
  • Turnover(Lac.)
  • ₹ 596
  • Day's High
  • ₹ 1,377
  • Day's Low
  • ₹ 1,328
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹
  • Face Value
  • ₹
  • Mkt Cap (₹ Cr.)
  • 0
  • P/E
  • EPS
  • Divi. Yield

undefined Corporate Actions

No Record Found


Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

undefined SHAREHOLDING SNAPSHOT
19 April , 2024 | 08:59 PM

PROMOTER - TOTAL51.12%

Indian: 0.00%

Foreign: 51.1183%

NON-PROMOTER - TOTAL 48.88%

Institutions: 18.38%

Non-Institutions: 30.50%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

undefined FINANCIALS

No Data Available To Display Chart

undefined PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT undefined

  • K K Maheshwari
  • Director
  • S S Lalbhai
  • Director
  • Vivek Dhariwal
  • Director
  • Neema Thakore
  • Company Secretary & Legal Dir.
  • Sekhar Natarajan
  • Director
  • S Sridhar
  • Director
  • Aijaz Tobaccowalla
  • Managing Director

Summary

Wyeth Ltd, a subsidiary of Wyeth, USA is a global leader in pharmaceuticals, consumer healthcare and animal health products. The company is a market leader in oral contraceptives, hormone Therapy, folic acid and depilatory cream. The Company operates in two segments: pharmaceuticals and others. The pharmaceuticals segment comprises formulations. Formulations comprise oral contraceptives, hormone replacement therapy, antibiotics, vaccines, steroids and other prescription medicines. The others segment comprises over-the-counter pharmaceuticals, cosmetics and other allied consumer products. The company has state-of-the-art manufacturing facility in Goa. Wyeth pioneered the introduction of several new therapies in India. The company was the first to launch hormone therapy. In the field of vaccines, the company introduced vaccines against HIB and invasive pneumococcal disease in the country. Enbrel, a breakthrough treatment for rheumatoid arthritis and Rapamune, an immuno suppressant for prevention of rejection after renal transplant, Prevenar, a pneumococcal conjugate vaccine and Tygacil, the worlds first glycilcycline antibiotic, are among internationally known products launched by Wyeth Ltd in India. Wyeth Ltd was incorporated on September 20, 1947 as a private limited company under the name Lederle Laboratories (India) Ltd. Subsequently, the name was changed to Cynamid India Ltd after their conversion into a public limited company on November 1, 1965. Subsequently, as part of... Read More


Reports by


Reports by

Company FAQ

No Record Found